Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pantelis Sarafidis

Showing results (1-10 of 241) with videos related to

Pageof 25
Sort By:
Expert Opinion on Pharmacotherapy|February 20, 2020
Pharmacotherapy of hypertension in patients with pre-dialysis chronic kidney diseaseCharalampos Loutradis, Pantelis Sarafidis
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 13, 2021
Sex differences in the progression of kidney injury and risk of death in CKD patients: is different ambulatory blood pressure control the underlying cause?Pantelis Sarafidis, Michel Burnier
Diabetes Care|July 17, 2020
Diastolic Blood Pressure Does Not Influence Cardiovascular Outcomes in Type 2 Diabetes; or Does It?Pantelis Sarafidis, George Bakris
Annals of Internal Medicine|December 17, 2019
Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract InfectionsPantelis Sarafidis, Aikaterini Papagianni
Clinical Kidney Journal|March 11, 2025
Does low-dose spironolactone increase cardiovascular protection in patients with chronic kidney disease?Clara García-Carro, Pantelis Sarafidis
Journal of the American Society of Nephrology : JASN|January 21, 2026
Baxdrostat and Other Aldosterone Synthase Inhibitors for Uncontrolled Hypertension in CKD: A Long-Awaited New Option?Marieta P Theodorakopoulou, Pantelis Sarafidis
Clinical Kidney Journal|January 8, 2024
SGLT2 inhibitors and finerenone in non-diabetic CKD: a step into the (near) future?Marieta P Theodorakopoulou, Pantelis Sarafidis
Journal of Human Hypertension|August 12, 2020
SGLT-2 inhibitors and nephroprotection: current evidence and future perspectivesAlexia Piperidou, Charalampos Loutradis, Pantelis Sarafidis
Clinical Kidney Journal|June 4, 2021
Simplifying volume assessment with lung ultrasound in paediatric haemodialysis patientsCharalampos Loutradis, Pantelis Sarafidis, Carmine Zoccali
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 20, 2020
Benefits and risks of frequent or longer haemodialysis: weighing the evidencePantelis Sarafidis, Danai Faitatzidou, Aikaterini Papagianni
Pageof 25

Showing results (1-10 of 241) with videos related to

Sort By:
Pageof 25
Expert Opinion on Pharmacotherapy|February 20, 2020
Pharmacotherapy of hypertension in patients with pre-dialysis chronic kidney diseaseCharalampos Loutradis, Pantelis Sarafidis
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 13, 2021
Sex differences in the progression of kidney injury and risk of death in CKD patients: is different ambulatory blood pressure control the underlying cause?Pantelis Sarafidis, Michel Burnier
Diabetes Care|July 17, 2020
Diastolic Blood Pressure Does Not Influence Cardiovascular Outcomes in Type 2 Diabetes; or Does It?Pantelis Sarafidis, George Bakris
Annals of Internal Medicine|December 17, 2019
Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract InfectionsPantelis Sarafidis, Aikaterini Papagianni
Clinical Kidney Journal|March 11, 2025
Does low-dose spironolactone increase cardiovascular protection in patients with chronic kidney disease?Clara García-Carro, Pantelis Sarafidis
Journal of the American Society of Nephrology : JASN|January 21, 2026
Baxdrostat and Other Aldosterone Synthase Inhibitors for Uncontrolled Hypertension in CKD: A Long-Awaited New Option?Marieta P Theodorakopoulou, Pantelis Sarafidis
Clinical Kidney Journal|January 8, 2024
SGLT2 inhibitors and finerenone in non-diabetic CKD: a step into the (near) future?Marieta P Theodorakopoulou, Pantelis Sarafidis
Journal of Human Hypertension|August 12, 2020
SGLT-2 inhibitors and nephroprotection: current evidence and future perspectivesAlexia Piperidou, Charalampos Loutradis, Pantelis Sarafidis
Clinical Kidney Journal|June 4, 2021
Simplifying volume assessment with lung ultrasound in paediatric haemodialysis patientsCharalampos Loutradis, Pantelis Sarafidis, Carmine Zoccali
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 20, 2020
Benefits and risks of frequent or longer haemodialysis: weighing the evidencePantelis Sarafidis, Danai Faitatzidou, Aikaterini Papagianni
Pageof 25